X4 Pharmaceuticals, Inc. (XFOR)

X4 Pharmaceuticals Revenue

X4 Pharmaceuticals had revenue of $8.81M in the quarter ending June 30, 2026, with 346.33% growth. This brings the company's total for the last twelve months to $15.85M, down -51.65% year-over-year. In the year 2025, X4 Pharmaceuticals had annual revenue of $35.11M with 1,273.21% growth. That makes X4 Pharmaceuticals the 35,087th largest company in the world by revenue and 4,625th in the United States.

• Revenue (ttm): $15.85M
• Revenue Growth: -51.65%
• P/S Ratio: 20.27
• Revenue / Employee: $352,156
• Employees: 45
• Market Cap: 321.24M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• United Kingdom 28.60M 81.5%
• United States 6.50M 18.5%

Fiscal year ended Dec 31, 2025 See the full X4 Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	35.11M	32.56M	1,273.21%
Dec 31, 2024	2.56M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 6, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error